Memorial Sloan-Kettering Cancer Center - New York — New York, New York

Memorial Sloan-Kettering Cancer Center - New York is a clinical research site located in New York, New York, United States 10065.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Memorial Sloan-Kettering Cancer Center - New York has participated in 3 clinical trials.

Therapeutic areas: Relapsed Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Myeloid Leukemia, Chronic, Chronic Phase.

Sponsors: ADC Therapeutics S.A., Takeda, Jazz Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Memorial Sloan-Kettering Cancer Center - New York?

Memorial Sloan-Kettering Cancer Center - New York has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Memorial Sloan-Kettering Cancer Center - New York conducted?

Memorial Sloan-Kettering Cancer Center - New York has 3 clinical trials on record. Their work covers Relapsed Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Myeloid Leukemia, Chronic, Chronic Phase.

Is Memorial Sloan-Kettering Cancer Center - New York accredited by Crixeo Health?

Memorial Sloan-Kettering Cancer Center - New York has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Memorial Sloan-Kettering Cancer Center - New York?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.